Patent details

Basic Information

Publication number:

EP3668853

PCT Application Number:

EP2018072144

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP187521729

PCT Publication Number:

WO2019034701

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL COMPOUNDS

French Title of Invention:

NOUVEAUX COMPOSÉS

German Title of Invention:

NEUARTIGE VERBINDUNGEN

SPC Number:

Dates

Filing date:

15/08/2018

Grant date:

29/09/2021

EP Publication Date:

24/06/2020

PCT Publication Date:

21/02/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/09/2021

EP B1 Publication Date:

29/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/08/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/04/2025

 

 

Name:

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

Address:

GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

From:

22/09/2021

 

 

Name:

Bioversys AG

Address:

Technologiepark Basel Hochbergerstrasse 60c, 4057 Basel, Switzerland (CH)

History of Owners

From:

22/09/2021

To:

17/04/2025

Name:

GlaxoSmithKline Intellectual Property Development Limited

Address:

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:

ARONOVA S.A.

From:

24/11/2021

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

REMUIÑAN-BLANCO, Modesto Jesús

Address:

Spain (ES)

2

Name:

PORRAS DE FRANCISCO, Esther

Address:

Spain (ES)

3

Name:

BOUROTTE, Marilyne

Address:

France (FR)

4

Name:

DEPREZ, Benoit

Address:

France (FR)

5

Name:

WILLAND, Nicolas

Address:

France (FR)

Priority

Priority Number:

17382570

Priority Date:

16/08/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07D 401/04; A61K 31/4427; A61K 31/4523; A61K 31/497; A61K 31/501; A61K 31/506; A61P 31/06;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2025/07

Publication date:

04/06/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

202139

Publication date:

29/09/2021

Description:

Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20250000145A

Date Registered:

17/04/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

ARONOVA S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

Bioversys AG

Address:

Technologiepark Basel Hochbergerstrasse 60c, 4057 Basel, Switzerland (CH)

2

Name:

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

Address:

GSK Medicines Research Centre Gunnels Wood Road, SG1 2NY, STEVENAGE, United Kingdom (GB)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

31/08/2026

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/07/2025

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
24/11/2021	Outgoing Correspondence	1
24/11/2021	Power Of Attorney	1
17/04/2025	Request For Change	1
12/05/2025	Outgoing Correspondence	1